American Soc. of Breast Surgeons

Adoption of breast-conserving therapy may be accelerated

Published in Health Risk Factor Week, May 3rd, 2005

Tens of thousands of women suffering from breast cancer opt for full mastectomies or for lumpectomies without radiation therapy, despite significant clinical evidence demonstrating that lumpectomies followed by radiation therapy have equivalent survival rates to full mastectomies.

Now, a new technology designed to deliver localized, non-radioactive radiation treatment directly to cancer sites may significantly increase access to radiation treatment and thus demand for breast-conserving therapy, according to a multidisciplinary panel of physicians here at the recently concluded 6th Annual Meeting of the American Society of Breast Surgeons (ASBS).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Risk Factor Week

Source: Health Risk Factor Week (2005-05-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry